{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T21:59:05Z","timestamp":1787695145039,"version":"build-2784847793"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,11,19]],"date-time":"2008-11-19T00:00:00Z","timestamp":1227052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00213-008-1393-3","type":"journal-article","created":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T07:51:04Z","timestamp":1226994664000},"page":"241-250","source":"Crossref","is-referenced-by-count":30,"title":["Substitution profile of \u03949-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating \u03949-tetrahydrocannabinol"],"prefix":"10.1007","volume":"203","author":[{"given":"Joshua A.","family":"Lile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Pinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon R.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,19]]},"reference":[{"key":"1393_CR1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.drugalcdep.2007.11.007","volume":"94","author":"S Babalonis","year":"2008","unstructured":"Babalonis S, Emurian CS, Martin CA, Lile JA, Kelly TH (2008) Modulation of the discriminative-stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women. Drug Alcohol Depend 94:276\u2013280","journal-title":"Drug Alcohol Depend"},{"key":"1393_CR2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF02245942","volume":"118","author":"RL Barrett","year":"1995","unstructured":"Barrett RL, Wiley JL, Balster RL, Martin BR (1995) Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats. Psychopharmacology 118:419\u2013424","journal-title":"Psychopharmacology"},{"key":"1393_CR3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/nbdi.1998.0229","volume":"5","author":"CS Breivogel","year":"1998","unstructured":"Breivogel CS, Childers SR (1998) The functional neuroanatomy of brain cannabinoid receptors. Neurobiol Dis 5:417\u2013431","journal-title":"Neurobiol Dis"},{"key":"1393_CR4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.60.1.155","volume":"60","author":"CS Breivogel","year":"2001","unstructured":"Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60:155\u2013163","journal-title":"Mol Pharmacol"},{"key":"1393_CR5","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1002\/j.1552-4604.1981.tb02599.x","volume":"21","author":"RG Browne","year":"1981","unstructured":"Browne RG, Weissman A (1981) Discriminative stimulus properties of delta 9-tetrahydrocannabinol: mechanistic studies. J Clin Pharmacol 21:S227\u2013S234","journal-title":"J Clin Pharmacol"},{"key":"1393_CR6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00421108","volume":"46","author":"OF Bueno","year":"1976","unstructured":"Bueno OF, Carlini EA, Finkelfarb E, Suzuki JS (1976) Delta 9-Tetrahydrocannabinol, ethanol and amphetamine as discriminative stimuli-generalization tests with other drugs. Psychopharmacologia 46:235\u2013243","journal-title":"Psychopharmacologia"},{"key":"1393_CR7","unstructured":"Cesamet Product Information (2006) Valeant Pharmaceuticals International"},{"key":"1393_CR8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02245145","volume":"107","author":"LD Chait","year":"1992","unstructured":"Chait LD, Zacny JP (1992) Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans. Psychopharmacology 107:255\u2013262","journal-title":"Psychopharmacology"},{"key":"1393_CR9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF00176846","volume":"94","author":"LD Chait","year":"1988","unstructured":"Chait LD, Evans SM, Grant KA, Kamien JB, Johanson CE, Schuster CR (1988) Discriminative stimulus and subjective effects of smoked marijuana in humans. Psychopharmacology 94:206\u2013212","journal-title":"Psychopharmacology"},{"key":"1393_CR10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1615\/CritRevNeurobiol.v13.i3.20","volume":"13","author":"F Chaperon","year":"1999","unstructured":"Chaperon F, Thiebot MH (1999) Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13:243\u2013281","journal-title":"Crit Rev Neurobiol"},{"key":"1393_CR11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02245916","volume":"102","author":"JP Chen","year":"1990","unstructured":"Chen JP, Paredes W, Li J, Smith D, Lowinson J, Gardner EL (1990) Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 102:156\u2013162","journal-title":"Psychopharmacology"},{"key":"1393_CR12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0022-3565(25)38122-X","volume":"265","author":"DR Compton","year":"1993","unstructured":"Compton DR, Rice KC, DeCosta BR, Razdan RK, Melvin LS, Johnson MR, Martin BR (1993) Cannabinoid structure\u2013activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265:218\u2013226","journal-title":"J Pharmacol Exp Ther"},{"key":"1393_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0006-8993(94)91811-2","volume":"641","author":"NJ DeSousa","year":"1994","unstructured":"DeSousa NJ, Beninger RJ, Jhamandas K, Boegman RJ (1994) Stimulation of GABAB receptors in the basal forebrain selectively impairs working memory of rats in the double Y-maze. Brain Res 641:29\u201338","journal-title":"Brain Res"},{"key":"1393_CR14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1615\/CritRevNeurobiol.v16.i12.160","volume":"16","author":"L Fattore","year":"2004","unstructured":"Fattore L, Cossu G, Spano MS, Deiana S, Fadda P, Scherma M, Fratta W (2004) Cannabinoids and reward: interactions with the opioid system. Crit Rev Neurobiol 16:147\u2013158","journal-title":"Crit Rev Neurobiol"},{"key":"1393_CR15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jnr.1224","volume":"66","author":"L Ferraro","year":"2001","unstructured":"Ferraro L, Tomasini MC, Cassano T, Bebe BW, Siniscalchi A, O\u2019Connor WT, Magee P, Tanganelli S, Cuomo V, Antonelli T (2001) Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels. J Neurosci Res 66:298\u2013302","journal-title":"J Neurosci Res"},{"key":"1393_CR16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0022-3565(25)13043-7","volume":"253","author":"MW Fischman","year":"1990","unstructured":"Fischman MW, Foltin RW, Nestadt G, Pearlson GD (1990) Effects of desipramine maintenance on cocaine self-administration. J Pharmacol Exp Ther 253:160\u2013170","journal-title":"J Pharmacol Exp Ther"},{"key":"1393_CR17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0166-2236(03)00227-3","volume":"26","author":"TF Freund","year":"2003","unstructured":"Freund TF (2003) Interneuron diversity series: rhythm and mood in perisomatic inhibition. Trens Neurosci 26:489\u2013495","journal-title":"Trens Neurosci"},{"key":"1393_CR18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","volume":"83","author":"TF Freund","year":"2003","unstructured":"Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017\u20131066","journal-title":"Physiol Rev"},{"key":"1393_CR19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/sj.bjp.0705593","volume":"141","author":"M Frosini","year":"2004","unstructured":"Frosini M, Valoti M, Sgaragli G (2004) Changes in rectal temperature and ECoG spectral power of sensorimotor cortex elicited in conscious rabbits by i.c.v. injection of GABA, GABA(A) and GABA(B) agonists and antagonists. Br J Pharmacol 141:152\u2013162","journal-title":"Br J Pharmacol"},{"key":"1393_CR20","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ahj.2005.11.006","volume":"151","author":"DA Gorelick","year":"2006","unstructured":"Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Huestis MA (2006) The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers. Am Heart J 151:754","journal-title":"Am Heart J"},{"key":"1393_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050422","volume":"134","author":"RR Griffiths","year":"1997","unstructured":"Griffiths RR, Weerts EM (1997) Benzodiazepine self-administration in humans and laboratory animals\u2014implications for problems of long-term use and abuse. Psychopharmacology 134:1\u201337","journal-title":"Psychopharmacology"},{"key":"1393_CR22","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0022-3565(25)20216-6","volume":"252","author":"RR Griffiths","year":"1990","unstructured":"Griffiths RR, Evans SM, Heishman SJ, Preston KL, Sannerud CA, Wolf B, Woodson PP (1990) Low-dose caffeine discrimination in humans. J Pharmacol Exp Ther 252:970\u2013978","journal-title":"J Pharmacol Exp Ther"},{"key":"1393_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(01)00287-1","volume":"106","author":"N Hajos","year":"2001","unstructured":"Hajos N, Ledent C, Freund TF (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106:1\u20134","journal-title":"Neuroscience"},{"key":"1393_CR24","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.npp.1301243","volume":"32","author":"M Haney","year":"2007","unstructured":"Haney M (2007) Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers. Neuropsychopharmacology 32:1391\u20131403","journal-title":"Neuropsychopharmacology"},{"key":"1393_CR25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00213-002-1231-y","volume":"164","author":"CL Hart","year":"2002","unstructured":"Hart CL, Ward AS, Haney M, Comer SD, Foltin RW, Fischman MW (2002) Comparison of smoked marijuana and oral delta 9-tetrahydrocannabinol in humans. Psychopharmacology 164:407\u2013415","journal-title":"Psychopharmacology"},{"key":"1393_CR26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1073858406296716","volume":"13","author":"Y Hashimotodani","year":"2007","unstructured":"Hashimotodani Y, Ohno-Shosaku T, Kano M (2007) Endocannabinoids and synaptic function in the CNS. Neuroscientist 13:127\u2013137","journal-title":"Neuroscientist"},{"key":"1393_CR27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF02244241","volume":"103","author":"SJ Heishman","year":"1991","unstructured":"Heishman SJ, Henningfield JE (1991) Discriminative-stimulus effects of d -amphetamine, methylphenidate, and diazepam in humans. Psychopharmacology 103:436\u2013442","journal-title":"Psychopharmacology"},{"key":"1393_CR28","first-page":"138","volume":"4","author":"SG Holtzman","year":"1988","unstructured":"Holtzman SG, Locke KW (1988) Neural mechanisms of drug stimuli: experimental approaches. Psychopharmacol Ser 4:138\u2013153","journal-title":"Psychopharmacol Ser"},{"key":"1393_CR29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archpsyc.58.4.322","volume":"58","author":"MA Huestis","year":"2001","unstructured":"Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA (2001) Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry 58:322\u2013328","journal-title":"Arch Gen Psychiatry"},{"key":"1393_CR30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-007-0861-5","volume":"194","author":"MA Huestis","year":"2007","unstructured":"Huestis MA, Boyd SJ, Heishman SJ, Preston KL, Bonnet D, Le Fur G, Gorelick DA (2007) Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology 194:505\u2013515","journal-title":"Psychopharmacology"},{"key":"1393_CR31","first-page":"328","volume":"94","author":"TU J\u00e4rbe","year":"1988","unstructured":"J\u00e4rbe TU, Hiltunen AJ (1988) Limited stimulus generalization between delta 9-THC and diazepam in pigeons and gerbils. Psychopharmacology 94:328\u2013331","journal-title":"Psychopharmacology"},{"key":"1393_CR32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00433555","volume":"63","author":"TU J\u00e4rbe","year":"1979","unstructured":"J\u00e4rbe TU, Ohlin GC (1979) Discriminative effects of combinations of delta 9-tetrahydrocannabinol and pentobarbital in pigeons. Psychopharmacology 63:233\u2013239","journal-title":"Psychopharmacology"},{"key":"1393_CR33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0091-3057(75)90048-9","volume":"3","author":"TU J\u00e4rbe","year":"1975","unstructured":"J\u00e4rbe TU, Johansson JO, Henriksson BG (1975) Delta9-tetrahydrocannabinol and pentobarbital as discriminative cues in the Mongolian Gerbil (Meriones unguiculatus). Pharmacol Biochem Behav 3:403\u2013410","journal-title":"Pharmacol Biochem Behav"},{"key":"1393_CR34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00213-006-0517-x","volume":"188","author":"TU J\u00e4rbe","year":"2006","unstructured":"J\u00e4rbe TU, Lamb RJ, Liu Q, Makriyannis A (2006) Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356). Psychopharmacology 188:315\u2013323","journal-title":"Psychopharmacology"},{"key":"1393_CR35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00213-003-1693-6","volume":"173","author":"Z Justinova","year":"2004","unstructured":"Justinova Z, Tanda G, Munzar P, Goldberg SR (2004) The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys. Psychopharmacology 173:186\u2013194","journal-title":"Psychopharmacology"},{"key":"1393_CR36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pbb.2005.01.026","volume":"81","author":"Z Justinova","year":"2005","unstructured":"Justinova Z, Goldberg SR, Heishman SJ, Tanda G (2005) Self-administration of cannabinoids by experimental animals and human marijuana smokers. Pharmacol Biochem Behav 81:285\u2013299","journal-title":"Pharmacol Biochem Behav"},{"key":"1393_CR37","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0026-895X(25)09130-8","volume":"42","author":"NE Kaminski","year":"1992","unstructured":"Kaminski NE, Abood ME, Kessler FK, Martin BR, Schatz AR (1992) Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol Pharmacol 42:736\u2013742","journal-title":"Mol Pharmacol"},{"key":"1393_CR38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1534582303262095","volume":"2","author":"TH Kelly","year":"2003","unstructured":"Kelly TH, Stoops WW, Perry AS, Prendergast MA, Rush CR (2003) Clinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures. Behav Cogn Neurosci Rev 2:227\u2013260","journal-title":"Behav Cogn Neurosci Rev"},{"key":"1393_CR39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00008877-200509000-00004","volume":"16","author":"TC Kirkham","year":"2005","unstructured":"Kirkham TC (2005) Endocannabinoids in the regulation of appetite and body weight. Behav Pharmacol 16:297\u2013313","journal-title":"Behav Pharmacol"},{"key":"1393_CR40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1525-1381.1999.09218.x","volume":"111","author":"AI Leshner","year":"1999","unstructured":"Leshner AI, Koob GF (1999) Drugs of abuse and the brain. Proc Assoc Am Physicians 111:99\u2013108","journal-title":"Proc Assoc Am Physicians"},{"key":"1393_CR41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drugalcdep.2004.04.010","volume":"76","author":"JA Lile","year":"2004","unstructured":"Lile JA, Stoops WW, Hays LR, Rush CR (2004) Tiagabine does not alter the discriminative-stimulus, reinforcing, subject-rated, performance or cardiovascular effects of oral cocaine in humans. Drug Alcohol Depend 76:81\u201391","journal-title":"Drug Alcohol Depend"},{"key":"1393_CR42","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1038\/sj.npp.1300803","volume":"30","author":"JA Lile","year":"2005","unstructured":"Lile JA, Stoops WW, Vansickel A, Glaser PEA, Hays LR, Rush CR (2005a) Aripiprazole attenuates the discriminative-stimulus effects of d-amphetamine in humans. Neuropsychopharmacology 30:2103\u20132114","journal-title":"Neuropsychopharmacology"},{"key":"1393_CR43","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pbb.2005.08.012","volume":"82","author":"JA Lile","year":"2005","unstructured":"Lile JA, Stoops WW, Wagner FP, Glaser PEA, Rush CR (2005b) Oxazepam does not modulate the behavioral effects of d-amphetamine in humans. Pharmacol Biochem Behavior 82:270\u2013279","journal-title":"Pharmacol Biochem Behavior"},{"key":"1393_CR44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1037\/1064-1297.14.2.136","volume":"142","author":"JA Lile","year":"2006","unstructured":"Lile JA, Stoops WW, Durell TM, Glaser PEA, Rush CR (2006) Discriminative-stimulus, self-reported, performance and cardiovascular effects of atomoxetine in methylphenidate-trained humans. Exp Clin Psychopharmacol 142:136\u2013147","journal-title":"Exp Clin Psychopharmacol"},{"key":"1393_CR45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pbb.2007.05.003","volume":"87","author":"JA Lile","year":"2007","unstructured":"Lile JA, Kendall SL, Babalonis S, Martin CA, Kelly TH (2007) Estradiol enhances the discriminative-stimulus and self-reported effects of d-amphetamine in healthy premenopausal women. Pharmacol Biochem Behav 87:289\u2013296","journal-title":"Pharmacol Biochem Behav"},{"key":"1393_CR46","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1016\/0306-4522(92)90409-U","volume":"48","author":"P Mailleux","year":"1992","unstructured":"Mailleux P, Vanderhaeghen JJ (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48:6555\u20136568","journal-title":"Neuroscience"},{"key":"1393_CR47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.euroneuro.2003.08.001","volume":"13","author":"R Maldonado","year":"2003","unstructured":"Maldonado R, Valverde O (2003) Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses. Eur Neuropsychopharmacol 13:401\u2013410","journal-title":"Eur Neuropsychopharmacol"},{"key":"1393_CR48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","volume":"20","author":"J Manzanares","year":"1999","unstructured":"Manzanares J, Corchero J, Romero J, Fern\u00e1ndez-Ruiz JJ, Ramos JA, Fuentes JA (1999) Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 20:287\u2013294","journal-title":"Trends Pharmacol Sci"},{"key":"1393_CR49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561\u2013564","journal-title":"Nature"},{"key":"1393_CR50","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1124\/jpet.106.107110","volume":"319","author":"LR McMahon","year":"2006","unstructured":"McMahon LR (2006) Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 319:1211\u20131218","journal-title":"J Pharmacol Exp Ther"},{"key":"1393_CR51","volume-title":"Profile of mood states [manual]","author":"DM McNair","year":"1971","unstructured":"McNair DM, Lorr M, Droppelman LF (1971) Profile of mood states [manual]. Educational and Industrial Testing Service, San Diego, CA"},{"key":"1393_CR52","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/sj.npp.1300957","volume":"31","author":"V Mendiz\u00e1bal","year":"2006","unstructured":"Mendiz\u00e1bal V, Zimmer A, Maldonado R (2006) Involvement of kappa\/dynorphin system in WIN 55,212-2 self-administration in mice. Neuropsychopharmacology 31:1957\u20131966","journal-title":"Neuropsychopharmacology"},{"key":"1393_CR53","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/0024-3205(86)90497-2","volume":"38","author":"DJ Mokler","year":"1986","unstructured":"Mokler DJ, Nelson BD, Harris LS, Rosecrans JA (1986) The role of benzodiazepine receptors in the discriminative stimulus properties of delta 9-tetrahydrocannabinol. Life Sci 38:1581\u20131589","journal-title":"Life Sci"},{"key":"1393_CR54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61\u201365","journal-title":"Nature"},{"key":"1393_CR55","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0014-2999(92)90302-K","volume":"219","author":"M Ohno","year":"1992","unstructured":"Ohno M, Yamamoto T, Wantanabe W (1992) Intrahippocampal injections of benzozdiazepines and muscimol impair working memory but not reference memory of rats in the three-panel runway task. Eur J Pharmacol 219:245\u2013251","journal-title":"Eur J Pharmacol"},{"key":"1393_CR56","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","volume":"1074","author":"ES Onaivi","year":"2006","unstructured":"Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi AP, Myers L, Mora Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, Arinami T, Teasenfitz, Uhl GR (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 1074:514\u2013536","journal-title":"Ann N Y Acad Sci"},{"key":"1393_CR57","first-page":"129","volume":"74","author":"RG Pertwee","year":"1997","unstructured":"Pertwee RG (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74:129\u2013180","journal-title":"Pharmacol Ther"},{"key":"1393_CR58","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0028-3908(88)90130-X","volume":"27","author":"RG Pertwee","year":"1988","unstructured":"Pertwee RG, Greentree SG (1988) Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide. Neuropharmacology 27:485\u2013491","journal-title":"Neuropharmacology"},{"key":"1393_CR59","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0028-3908(88)90029-9","volume":"27","author":"RG Pertwee","year":"1988","unstructured":"Pertwee RG, Greentree SG, Swift PA (1988) Drugs that stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol-induced to produce marked catalepsy in mice. Neuropharmacology 27:1265\u20131270","journal-title":"Neuropharmacology"},{"key":"1393_CR60","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0091-3057(91)90366-A","volume":"40","author":"RG Pertwee","year":"1991","unstructured":"Pertwee RG, Browne SE, Ross TM, Stretton CD (1991) An investigation of the involvement of GABA in certain pharmacological effects of delta-9-tetrahydrocannabinol. Pharmacol Biochem Behav 40:581\u2013585","journal-title":"Pharmacol Biochem Behav"},{"key":"1393_CR61","unstructured":"Physician\u2019s Desk Reference (2004) Medical Economics Company, Inc., Oradell, NJ"},{"key":"1393_CR62","first-page":"114","volume":"295","author":"KL Preston","year":"2000","unstructured":"Preston KL, Bigelow GE (2000) Effects of agonist\u2013antagonist opioids in humans trained in a hydromorphone\/not hydromorphone discrimination. J Pharmacol Exp Ther 295:114\u2013124","journal-title":"J Pharmacol Exp Ther"},{"key":"1393_CR63","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-3565(25)10991-9","volume":"261","author":"KL Preston","year":"1992","unstructured":"Preston KL, Liebson IA, Bigelow GE (1992) Discrimination of agonist\u2013antagonist opioids in humans trained on a two choice saline-hydromorphone discrimination. J Pharmacol Exp Ther 261:62\u201371","journal-title":"J Pharmacol Exp Ther"},{"key":"1393_CR64","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1292\/jvms.61.351","volume":"61","author":"M Rahminiwati","year":"1999","unstructured":"Rahminiwati M, Nishimura M (1999) Effects of delta 9-tetrahydrocannbinol and diazepam on feeding behavior in mice. J Vet Med Sci 61:351\u2013355","journal-title":"J Vet Med Sci"},{"key":"1393_CR65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pbb.2004.02.006","volume":"78","author":"SM Rawls","year":"2004","unstructured":"Rawls SM, Tallarida RJ, Kon DA, Geller EB, Adler MW (2004) GABAA receptors modulate cannabinoid-evoked hypothermia. Pharmacol Biochem Behav 78:83\u201391","journal-title":"Pharmacol Biochem Behav"},{"key":"1393_CR66","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00008877-199605000-00011","volume":"7","author":"J Romero","year":"1996","unstructured":"Romero J, Garc\u00eda-Palomero E, Fern\u00e1ndez-Ruiz JJ, Ramos JA (1996) Involvement of GABA(B) receptors in the motor inhibition produced by agonists of brain cannabinoid receptors. Behav Pharmacol 7:299\u2013302","journal-title":"Behav Pharmacol"},{"key":"1393_CR67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1037\/1064-1297.8.1.22","volume":"8","author":"CR Rush","year":"2000","unstructured":"Rush CR, Baker RW, Rowlett JK (2000) Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital and caffeine in zolpidem-trained humans. Exp Clin Psychopharmacology 8:22\u201336","journal-title":"Exp Clin Psychopharmacology"},{"key":"1393_CR68","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.102.048439","volume":"306","author":"CR Rush","year":"2003","unstructured":"Rush CR, Stoops WW, Hays LR, Glaser PE, Hays LS (2003) Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Pharmacol Exp Ther 306:195\u2013204","journal-title":"J Pharmacol Exp Ther"},{"key":"1393_CR69","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s00213-004-2118-x","volume":"179","author":"M Solinas","year":"2005","unstructured":"Solinas M, Goldberg SR (2005) Involvement of mu-, delta-, and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats. Psychopharmacology 179:804\u2013812","journal-title":"Psychopharmacology"},{"key":"1393_CR70","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1111\/j.0953-816X.2004.03420.x","volume":"19","author":"M Solinas","year":"2004","unstructured":"Solinas M, Zangen A, Thiriet N, Goldberg SR (2004) Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol. Eur J Neurosci 19:3138\u20133192","journal-title":"Eur J Neurosci"},{"key":"1393_CR71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1037\/1064-1297.13.1.56","volume":"13","author":"WW Stoops","year":"2005","unstructured":"Stoops WW, Lile JA, Glaser PEA, Rush CR (2005) Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine and triazolam in humans. Experiment Clin Psychopharmacol 13:56\u201364","journal-title":"Experiment Clin Psychopharmacol"},{"key":"1393_CR72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.drugalcdep.2006.02.004","volume":"84","author":"WW Stoops","year":"2006","unstructured":"Stoops WW, Lile JA, Glaser PEA, Rush CR (2006) A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug Alcohol Depend 84:206\u2013209","journal-title":"Drug Alcohol Depend"},{"key":"1393_CR73","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/3-540-26573-2_11","volume":"168","author":"B Szabo","year":"2005","unstructured":"Szabo B, Schlicker E (2005) Effects of cannabinoids on neurotransmission. Handb Exp Pharmacol 168:327\u2013365","journal-title":"Handb Exp Pharmacol"},{"key":"1393_CR74","doi-asserted-by":"crossref","unstructured":"van den Pol AN (2003) Weighing the role of hypothalamic feeding of neurotransmitters 40:1059\u20131061","DOI":"10.1016\/S0896-6273(03)00809-2"},{"key":"1393_CR75","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00213-004-1988-2","volume":"178","author":"SA Varvel","year":"2005","unstructured":"Varvel SA, Anum E, Niyuhire F, Wise LE, Lichtman AH (2005) Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABAA antagonoist bicuculline. Psychopharmacology 178:317\u2013327","journal-title":"Psychopharmacology"},{"key":"1393_CR76","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pbb.2005.01.021","volume":"81","author":"D Vigan\u00f2","year":"2005","unstructured":"Vigan\u00f2 D, Rubino T, Parolaro D (2005) Molecular and cellular basis of cannabinoid and opioid interactions. Pharmacol Biochem Behav 81:360\u2013368","journal-title":"Pharmacol Biochem Behav"},{"key":"1393_CR77","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-002-1033-2","volume":"161","author":"SR Wachtel","year":"2002","unstructured":"Wachtel SR, ElSohly MA, Ross SA, Ambre J, de Wit H (2002) Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. Psychopharmacology 161:331\u2013339","journal-title":"Psychopharmacology"},{"key":"1393_CR78","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0091-3057(99)00130-6","volume":"64","author":"JL Wiley","year":"1999","unstructured":"Wiley JL, Martin BR (1999) Effects of SR141716A on diazepam substitution for delta 9-tetrahydrocannabinol in rat drug discrimination. Pharmacol Biochem Behav 64:519\u2013522","journal-title":"Pharmacol Biochem Behav"},{"key":"1393_CR79","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0376-8716(95)01193-5","volume":"40","author":"JL Wiley","year":"1995","unstructured":"Wiley JL, Huffman JW, Balster RL, Martin BR (1995) Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys. Drug Alcohol Depend 40:81\u201386","journal-title":"Drug Alcohol Depend"},{"key":"1393_CR80","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/35069076","volume":"410","author":"RI Wilson","year":"2001","unstructured":"Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature 410:588\u2013592","journal-title":"Nature"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1393-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-008-1393-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1393-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T20:43:45Z","timestamp":1738529025000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-008-1393-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,19]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["1393"],"URL":"https:\/\/doi.org\/10.1007\/s00213-008-1393-3","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,19]]}}}